The THIN database is a valid data source for pharmacoepidemiology research, comparable to the GPRD.
No takes yet. Share an insight, caveat, or question.
Supports THIN as valid pharmacoepidemiology source; leaves open broader outcome generalizability.
Lewis et al. (2006) studied this question.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: